Background. Patients with coronary artery disease (CAD) are at considerable risk for subsequent cardiovascular events. Although hyperlipidemia accentuates the risk, predictors of subsequent events with CAD and desirable total cholesterol (TC) (<5.2 mmol/l) have not been assessed.
At least 7.2 million people in the United
currently suffer from symptomatic coronary artery disease (CAD)' and are at greatest risk for subsequent cardiovascular events.2 Because intensive lipid-lowering therapies have been efficacious in retarding and, in some instances, reversing established atherosclerotic lesions,34 the impetus toward identification and management of coronary risk factors has been bolstered in recent years. Although hyperlipidemia represents an important risk factor for development of both primary and secondary cardiovascular events, the primary event rate is high even without significant eleva- tions of total cholesterol (TC); approximately 50% of primary myocardial infarctions occur in subjects with TC<6.5 mmol/l, and 20% afflict those with desirable levels (<5.2 mmol/l). 5 Whereas several studies have demonstrated that reduced left ventricular ejection fraction (LVEF), hypertension, hyperlipidemia, cigarette smoking, and low levels of high density lipoprotein cholesterol (HDL-C)6-10 may be predictive of subsequent coronary events, these studies have not specifically addressed patients with desirable levels of TC. The fact that CAD heralds an increased risk of subsequent cardiovascular events despite "desirable" TC"I underscores the necessity of evaluating potentially modifiable risk factors within this subgroup.
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Methods
Enrollment of Patients
Seven hundred forty consecutive patients underwent diagnostic coronary angiography at the Johns Hopkins Hospital between March 1977 and April 1978. Approximately 180 patients were excluded from follow-up because of a recent myocardial infarction (within 3 months of angiography),12 heparinization preceding blood sampling,13 or active therapy with lipid-lowering drugs. Of the remaining patients, approximately one third had desirable TC, and nearly 60% (91 men and 27 women) had CAD or >50% stenosis in at least one major epicardial coronary artery segment14 and met the criteria for the study.
Data Collection
Beginning in 1988, after a thorough analysis of medical records, attempts were made to locate patients with CAD and desirable TC. Most of the subjects admitted to the Johns Hopkins Hospital for diagnostic coronary arteriography were referred from sources outside the institution and were not subsequently treated at the hospital.
Letters and follow-up questionnaires were submitted to family members, to referring physicians, and to patients at their last available residence. The questionnaires were designed to elicit information regarding subsequent illnesses and hospitalizations after catheterization. The time interval of those successfully followed up without end points was 13 years. When neither patient nor family member could be located, letters were sent to the Social Security Administration and motor vehicle agency of the patient's home state. To verify a reported history of a subsequent cardiovascular event (see below), copies of hospital and physician records, death certificates, and autopsy reports were also acquired. Through these mechanisms, data were collected through 1990 for 91% of the study cohort. A search of the National Death Index identified no further end points. There were no significant differences in risk factor profiles between the 11 subjects lost to follow-up and the study subjects ( Table 1) .
Coronary artery bypass graft surgery (CABG) was performed in approximately 40% of subjects, usually within 3 months of the 1977-1978 coronary arteriogram. CABG scheduled in accordance with the 1977-1978 arteriogram was not recorded as an end point. Patients were followed for a new cardiovascular event, not related to the initial coronary arteriography, defined by one of the following three end points: 1) cardiovascular death as the underlying cause based on the International Classification of Diseases, Clinical Modification15 (ICD-9-CM Codes 410-448); 2) myocardial infarction, defined as prolonged chest pain and characteristic electrocardiographic and enzymatic changes16; and 3) refractory ischemia requiring CABG or percutaneous transluminal coronary angioplasty (PTCA); non-surgically amenable total occlusions of either saphenous vein grafts or nonbypassed native vessels were also included. Table 2 lists the subsequent cardiovascular events; a maximum of one event per patient was recorded as an end point.
Risk Factor Assessment
During the 1977-1978 cardiac catheterization, plasma lipid and lipoprotein levels were determined as previously described,17 as were indexes of cardiac function from the left ventriculogram (i.e., LVEF). In addition, risk factor assessment included a history of cigarette smoking, diabetes mellitus, family history of CAD, hypertension, obesity defined as body mass index >27, sedentary lifestyle, and the presence of lipoprotein(a) [Lp(a)].17 The use of /3-blockers was also assessed, because these medications may reduce the concentrations of HDL-C18; however, there were no significant differences in the mean baseline levels of HDL-C in those receiving (0.89+±0.23 mmol/l) or not receiving (0.89+0.22 mmol/l) this class of drug.
Statistical Analysis
To minimize any biases in data collection, results of the 1977-1978 risk factor questionnaires, stored in the SAS data base system, were not made available until receipt of follow-up information. Then, CAD subjects were grouped into those developing or not developing subsequent cardiovascular events. Continuous and categorical variables were analyzed by Student's t test and X2 analysis, respectively. In some cases, nonparametric (Wilcoxon rank sum) tests were used. The Cox proportional-hazards regression model was used to estimate the effect of various age-adjusted risk factors as independent predictors of subsequent cardiovascular events, and the Kaplan-Meier survival analysis was used to compare the time-to-event rate between subjects with and without low HDL-C. 19 Categorical variables including HDL-C <0.9 mmol/l (35 mg/dl), as defined by the National Cholesterol Education Program,20 and an LVEF <35% (a known predictor of recurrent cardiac events)21 were used. Relative risks (RR) and the corresponding 95% confidence interval (CI) were estimated for each statistically significant covariate. Table 2 details the subsequent cardiovascular events experienced in 83 men and 24 women with CAD who had desirable TC at baseline in 1977-1978. Of the 65 events, 45% were cardiovascular deaths. During the next decade, 13 patients required CABG (initial or repeat) or PTCA, and seven patients developed total occlusion of a saphenous vein graft or a nonbypassed native vessel; these events occurred independently of symptoms leading to the original coronary arteriogram. Compared with the medically managed group, the baseline values of triglyceride (TG), TC: HDL-C ratio, and body mass index were significantly higher in the surgically treated patients (Table 3 ). Subsequent cardiovascular event rate, however, was not significantly different between the two groups (63% of CABG and 59% of medically treated subjects had new events during follow-up).
Results
The mean levels of lipids, lipoproteins, and other selected variables at baseline are depicted in Table 4 . Patients who developed new cardiovascular events had similar ages, mean levels of TC, low density lipoprotein cholesterol (LDL-C), coronary vessels with >50% stenosis, and body mass index compared with event-free subjects. Mean levels of HDL-C and the TC:HDL-C ratio were significantly different in patients developing subsequent events (p=0.013 and p=0.003, respectively). The mean TG was higher and LVEF lower in this group, although both were of borderline significance (p=0.07 and p=0.08).
The prevalence of selected risk factors in patients with and without new cardiovascular events is shown in Table 5 . At baseline, the majority of CAD men were cigarette smokers and were sedentary (but not obese) whether or not they developed subsequent cardiovascular events. In contrast, although diabetes mellitus was not particularly prevalent, its presence translated into a substantially greater risk for new events (p=0.02). A positive family history of CAD was of borderline significance (p=0.06). The presence of elevated Lp(a) was exceedingly rare in this subgroup and was detected at baseline in only one male and two female subjects as a sinking pre-/8-lipoprotein band.
A quartile analysis of HDL-C, LDL-C, and TG is presented in Figure 1 . The rate of new events in the lowest HDL-C quartiles was significantly greater compared with the highest quartiles (p=0.01). Of CAD subjects with baseline HDL-C below the median (0.9 mmol/l), 75% suffered a new cardiovascular event compared with 45% with HDL-C .0.9 mmol/l (p=0.002). There were no differences in subsequent event rate based on LDL-C or TG quartile distributions. A Kaplan-Meier survival analysis (Figure 2 ) demonstrates a markedly accelerated event rate in subjects with baseline HDL-C <0.9 mmol/l compared with HDL-C >0.9 mmol/l (p=0.005). It is noteworthy that the reduction in survival in the low HDL-C subjects became prominent after 50 months of follow-up, with a precipitous drop in survival between 80 and 140 months. To assess the independent effect of selected risk factors as predictors of subsequent cardiovascular events, an age-adjusted Cox proportional-hazards model was used. The baseline independent variables tested were a positive family history of CAD, hypertension, diabetes mellitus, smoking history, recipients of Positive family history 63 60t 41 41 Hypertension 65 40 42 43 Obesity (BMI >27) 58 21 30 28 Sedentary lifestyle been present at baseline. Whereas selected risk factors have been extensively studied in hyperlipidemic CAD subjects,7'22'23 the impact of these predictors in patients with desirable TC has been lacking. Previously, HDL-C and the TC:HDL-C ratio had been shown to be independent predictors of primary coronary events in hyperlipidemic subjects.24 25 Furthermore, enhanced rates of mortality were found in hyperlipidemic myocardial infarction survivors with the lowest HDL-C levels.10'26 When the TC is desirable, however, low HDL-C (or a high ratio of TC:1HDL-C) not only is predictive of initial cardiovascular events in middle-aged adults27,28 but also is highly prevalent among angiographically documented CAD patients.17'29-32Nevertheless, the National Cholesterol Education Program presented no recommendations for the identification of these subjects20; this may have stemmed, in part, from the lack of data demonstrating the importance of low HDL-C as a predictor of subsequent coronary events when LDL-C and TC are not elevated.33 Our findings support recent recommendations of a National Institutes of Health Consensus Conference that HDL-C levels should be identified in all CAD patients.
There are several mechanisms whereby a low level of HDL-C may predispose to atherogenesis even when LDL-C or TC levels are desirable. Believed to be a primary mediator of reverse cholesterol transport, HDL-C incorporates extrahepatic cholesterol for direct removal either via putative hepatic receptors or by transfer to lower density lipoproteins in exchange for triglyceride, a process mediated by cholesteryl ester transfer protein. 34 If HDL-C levels are low, then removal of excess unesterified cholesterol in vascular tissues may be impeded, resulting in uptake by scavenger cells and enhanced cholesteryl ester deposition in reticuloendothelial organs35 or accelerated atherosclerosis in both coronary and extracoronary sites. [36] [37] [38] After endothelial damage has been sustained, development and progression of the eventual fibrous plaque retards cholesterol egress from atherosclerosis-prone sites39; in patients with established CAD, a low level of HDL-C, therefore, may accentuate this process, independent of the plasma concentration of LDL-C.
It could be speculated that the decreased survival in the low HDL-C group was in fact a result of accelerated atherogenesis and not a consequence of reduced left ventricular function or greater number of stenotic vessels at baseline. During the first 60 months of follow-up, there were similar decrements in event-free survival between the dichotomized HDL-C groups (Figure 2 ). These early events were more likely to occur in patients with compromised LV function at baseline; the mean LVEF was 50.6% with event-free survival <60 months compared with 61.1% with event-free survival >60 months (p=0.0007). Moreover, despite the equal severity of CAD (based on the number of diseased vessels) noted at baseline (Table 4) , the individuals with low HDL-C had more subsequent cardiovascular events, with these events transpiring with marked rapidity beyond 80 months of follow-up.
A number of potential mechanisms may link the acceleration of coronary atherosclerosis to low levels of HDL-C. These include the greater magnitude of postprandial lipemia exhibited in those with low compared
.. E.. ..s (1A-: -with higher HDL-C,40 resulting in reduced clearance of potentially atherogenic triglyceride-rich remnant particles. In addition, there is an association between low HDL-C and hyper-apo B, a lipoprotein phenotype defined as increased concentrations of apolipoprotein B (apo B), the primary apolipoprotein of LDL, but normal or modestly elevated LDL-C levels. 41 In the Montreal Heart Institute Study,42 both elevated apo B and reduced HDL-C were the best predictors for the development of saphenous vein bypass graft atherosclerosis. We found reduced HDL-C in CABG subjects who developed graft occlusions compared with those who did not (0.78+0.19 mmol/l versus 0.90+0.16 mmol/l; p=0.07). Unfortunately, apo B was not routinely measured at the time this study was initiated; however, analysis of the highest triglyceride and lowest HDL quartile disclosed 13 subjects who may have approximated the hyper-apo B phenotype. 43 Low HDL-C may also accompany disorders of glucose metabolism. In the present study, three patients met the criteria for syndrome X, a disorder characterized by insulin resistance, hyperglycemia, hypertension, hypertriglyceridemia, and central adiposity. 44 Interestingly, HDL-C was not significantly different in the 18 diabetic (0.89+±0.35 mmol/l) versus nondiabetic subjects (0.89+±0.19 mmol/l). Although the RR for subsequent events with diabetes mellitus was 2.9 (95% CI, 1.6,5.1; p<0.001), it was very highly correlated with ejection fraction, the most potent predictor of new events in the study (mean ejection fraction in diabetic patients, 47.1% versus nondiabetics, 59.5%; p=0.001). Consequently, diabetes mellitus did not enter into the Cox proportional-hazards model. It is noteworthy that the vast majority of patients with low HDL-C in the present study were neither diabetic, hypertriglyceridemic, nor obese.
Perhaps the most intriguing hypothesis linking low levels of HDL-C to CAD is the recent identification of apolipoprotein A-1, the primary apolipoprotein of HDL-C, as the prostacyclin-stabilizing factor45; in patients with unstable angina or myocardial infarction, low levels of HDL-C coincided with marked reductions in the serum half-life of prostacyclin,"6 a prostaglandin (PGI2) with potent vasodilatory and antiplatelet aggregatory properties.
Because of the high risk of recurrent coronary events, we and others believe that all patients with CAD should have lipoprotein measurements to screen for dyslipidemias, regardless of TC.2,17,29-32 Furthermore, dietary measures to reduce total fat consumption to .30% of caloric intake as recommended by the American Heart Association should be adopted.20 Of fats consumed, recent data indicate that replacement of saturates with monounsaturates or polyunsaturates reduces TC and LDL-C without adversely affecting HDL-C.47 Whether high-carbohydrate diets or a caloric intake comprising <20% fat (which often reduces HDL-C but also lowers LDL-C and TC:HDL-C) impacts favorably in this subgroup as previously reported in hyperlipidemic sub-jects48 requires further study. Nevertheless, even when TC is "desirable," hygienic measures may reduce progression of coronary lesions when combined with intensive lipid-lowering therapy. 4 Despite the presence of desirable TC, CAD subjects with low HDL-C were at very high risk of developing a subsequent cardiovascular event. In the Helsinki Heart Study,49 HDL-C elevation independently reduced coronary event rate, but this study did not examine subjects with desirable TC. A large clinical trial will be necessary to determine whether raising low HDL-C in normocholesterolemic subjects significantly reduces CAD events. Alternatively, if low HDL-C cannot be elevated by these approaches, reduction of LDL-C or TC to the "physiological" range50 may be appropriate. The recent demonstrations that HDL-C or its primary apolipoprotein, apo A-1, may directly induce atherosclerotic regression or inhibit early atherogenesis5152 provide further support that this potentially modifiable risk factor deserves a greater place in the overall scheme of lipoprotein detection and management.
